The interventional reference point is standardized by the International Electrotechnical Commission (IEC), and is adapted to adult cardiovascular studies. We examined the precision of the indicated incident dose at the interventional reference point. As a fundamental examination, we compared entrance phantom dose and incident dose at the interventional reference point. We also compared the entrance skin dose of patients with incident dose at the interventional reference point and evaluated the possibility of clinical application. Results showed that the incident dose at the interventional reference point indicated an underestimation of 0.77 times to an overestimation of 2.2 times when representing entrance surface dose. In clinical application, the incident dose at the interventional reference point calculated from the dose area product tended to overestimate by about 1.17 times the entrance skin dose measured by thermoluminescence dosimeter (TLD). Furthermore, the evaluation varied according to the angles of the C-arm of the x-ray system. A interventional reference point is a useful standard for simple, real-time dose measurement by the indirect method. It is important to understand the characteristics of the indicated incident dose at the interventional reference point in clinical use.
[1]
T. Araki,et al.
Exposure doses for the operator and patient in blood access intervention therapy (BAIVT)
,
2003
.
[2]
H. Mizutani.
[Research on the measurement of patient dose and protection in IVR].
,
2003,
Nihon Hoshasen Gijutsu Gakkai zasshi.
[3]
J I Ten,et al.
Skin radiation injuries in patients following repeated coronary angioplasty procedures.
,
2001,
The British journal of radiology.
[4]
T. Shope,et al.
Radiation-induced skin injuries from fluoroscopy.
,
1996,
Radiographics : a review publication of the Radiological Society of North America, Inc.
[5]
英秀 新開,et al.
Evaluation of Characteristics of Newly Developed Small-Electrode Ionization Chamber for Measuring Patient Exposure
,
1996
.
[6]
W J Wajszczuk,et al.
Radiation exposure to patients undergoing percutaneous transluminal coronary angioplasty.
,
1987,
The American journal of cardiology.
[7]
A. Togashi.
Considering of Radiation Protection from the Report on the Dermatopathy by IVR
,
2001
.
[8]
T. Araki,et al.
A Study of Patient's Dose Control Using an Area Exposure Product Meter
,
2000
.